Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25567180 | 0.84 | DDB1 (0.53) | DDB1CRBN | |
| SCHEMBL24890984 | 0.79 | CRBN (0.50) | DDB1CRBN | |
| SCHEMBL24890983 | 0.79 | CRBN (0.50) | DDB1CRBN | |
| SCHEMBL24890981 | 0.79 | CRBN (0.50) | DDB1CRBN | |
| SCHEMBL23798048 | 0.79 | DDB1 (0.54) | DDB1CRBN | |
| SCHEMBL25091486 | 0.76 | DDB1 (0.57) | DDB1CRBN | |
| SCHEMBL25091497 | 0.76 | DDB1 (0.57) | DDB1CRBN | |
| SCHEMBL25091488 | 0.75 | DDB1 (0.71) | DDB1CRBN | |
| SCHEMBL23798693 | 0.74 | DDB1 (0.61) | DDB1CRBN | |
| SCHEMBL25091822 | 0.74 | DDB1 (0.48) | DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691972-B2 | Compounds for targeted degradation of BRD9 | C4 THERAPEUTICS, INC. (US) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691972-B2 | Compounds for targeted degradation of BRD9 | BRD9, BRD1, BRWD1 | DDB1 390/4885CRBN 188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.